Shai Mulinari

1 – 10 of 81

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/medk-smu?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
8
9
next »

2023
Mark Conceptual unclarity about COVID-19 ethnic disparities in Sweden: Implications for public health policy
Bredström, Anna and Mulinari, Shai ^LU (2023) In Health 27(2). p.186-200
- Contribution to journal › Article
Mark International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
Ozieranski, Piotr ; Saito, Hiroaki ; Rickard, Emily ; Mulinari, Shai ^LU and Ozaki, Akihiko (2023) In Globalization and Health 19(14). p.1-42
- Contribution to journal › Article
Mark Short-circuiting biology: Digital phenotypes, digital biomarkers, and shifting gazes in psychiatry
Mulinari, Shai ^LU (2023) In Big Data and Society
- Contribution to journal › Article
2022
Mark A “patient-industry complex”? Investigating the financial dependency of UK patient organisations on drug company funding
Ozieranski, Piotr ; Janos, Pitter ; Rickard, Emily ; Mulinari, Shai ^LU and Csanadi, Marcell (2022) In Sociology of Health & Illness 44(1). p.188-210
- Contribution to journal › Article
Mark The making of a Swedish strategy : How organizational culture shaped the Public Health Agency's pandemic response
Olofsson, Tobias ^LU ; Mulinari, Shai ^LU ; Hedlund, Maria ^LU ; Knaggård, Åsa ^LU and Vilhelmsson, Andreas ^LU (2022) In SSM Qualitative Research in Health 2.
- Contribution to journal › Article
Mark Capitalizing on transparency: commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act
Mulinari, Shai ^LU and Ozieranski, Piotr (2022) In Big Data and Society 9(1).
- Contribution to journal › Article
Mark Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
Pashley, Dylan ^LU ; Ozieranski, Piotr and Mulinari, Shai ^LU (2022) In International Journal of Health Services 52(3). p.347-362
- Contribution to journal › Article
Mark Tip of the iceberg? Country- and company-level analysis of drug company payments for research and development in Europe
Ozieranski, Piotr ; Martinon, Luc ; Jachiet, Pierre-Alain and Mulinari, Shai ^LU (2022) In International Journal of Health Policy and Management 11(12). p.2842-2859
- Contribution to journal › Article
Mark Content and strength of conflict of interest policies at Scandinavian Medical Schools: a cross sectional study
Fabbri, Alice ; Mulinari, Shai ^LU ; Johansson, Martin ^LU ; Ghaur, Weda ; Khalil, Abdullah Muhammad and Lundh, Andreas (2022) In BMC Medical Education 22.
- Contribution to journal › Article
Mark “Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation
Mulinari, Shai ^LU and Bredström, Anna (2022) In BioSocieties
- Contribution to journal › Article

« previous
1
2
3
4
…
8
9
next »